Complex neurodevelopmental disorder and eligible disability changes to MBS items

This page provides details of the 1 March 2023 changes to MBS items relating to Complex Neurodevelopmental Disorders and eligible disabilities

Page last updated: 08 February 2023

From 1 March 2023, the age of eligibility to receive Medicare rebates for a Complex Neurodevelopmental Disorder or Eligible Disability will lift from under 13 to under 25. Additionally, terminology has been updated from “Pervasive Developmental Disorder” to Complex Neurodevelopmental Disorder to reflect contemporary language.

The number of assessment services has increased from 4 to 8 and the list of eligible disabilities has been expanded. These changes have been made as the result of recommendations from the MBS Review Taskforce and consultation with stakeholders.

Further information is available in the following Factsheet and Quick Reference Guides:

Document
PDF and Word versions
Factsheet - Complex Neurodevelopmental Disorders and Eligible Disabilities - 1 March 2023 changes
(Last updated:2 February 2023)
Word Version Factsheet - Complex Neurodevelopmental Disorders and Eligible Disabilities - 1 March 2023 changes (Word 129 KB)

PDF Version Factsheet - Complex Neurodevelopmental Disorders and Eligible Disabilities - 1 March 2023 changes (PDF 245 KB)
Quick Reference Guide - 1 March 2023 changes for items 135 137 139 and 289 (Last updated:2 February 2023)Word Version Quick Reference Guide - 1 March 2023 changes for items 135 137 139 and 289 (Word 144 KB)

PDF Version Quick Reference Guide - 1 March 2023 changes for items 135 137 139 and 289 (PDF 230 KB)
Quick Reference Guide - 1 March 2023 Allied Health MBS Item Changes (Last updated:2 February 2023)Word Version Quick Reference Guide - 1 March 2023 Allied Health MBS Item Changes (Word 146 KB)

PDF Version Quick Reference Guide - 1 March 2023 Allied Health MBS Item Changes (PDF 325 KB)

In this section